Hemispherx BioPharma, Inc. (AMEX:HEB)
| CAPS Rating |
|
|---|
HEB
VS S&P 500 (SPY)
HEB News and Commentary
- Mediocre 4Q for H-P - Analyst Blog – NASDAQ
- One Small Cap for the Coming Rally – The Motley Fool
- Three Penny Stocks to Avoid (HEB) (CIT) (IRLD) – Blog at The Motley Fool
- Buy Before It's Too Late – The Motley Fool
- What are some pharmaceutical stocks that will be reviewed by the FDA soon? – Blog at The Motley Fool
- Correct me if I am wrong, but I think I have found a gem – Blog at The Motley Fool
- H1N1 R&D Biotechs, More Virulent Than The Flu Strain Itself? – Blog at The Motley Fool
- This Move Cost Index Funds Big Money – The Motley Fool
- 6 Stocks to Sell Before Everyone Else Does – The Motley Fool
This ticker is not currently Ratable.
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
104
Outperform
75
Underperform
All-Star Players
16
Outperform
30
Underperform
Wall Street
0
Outperform
0
Underperform
RSS Headlines
Fool UK
